Skip to content

CAPRICOR THERAPEUTICS, INC.

CAPR

CIK 0001133869

← back to feed
Revenue (TTM)
$17.33M
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$108.81M
−159.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.23
−96.5% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-668.1%
Q1 May 2026
Net Margin
-628.0%
Q1 May 2026
Free Cash Flow (TTM)
−$39.72M
Q1 May 2026
Cash
$105.42M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
57.91M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings